Bellus Health
Biotechnology Research • 
Laval, Quebec, Canada • 11-20 Employees
Company overview
| Headquarters | 275 Armand Frappier, Laval, Quebec H7V4A7, CA |
| Phone number | +14506804500 |
| Websites | |
| NAICS | 541714 |
| SIC | 283 |
| Employees | 11-20 |
| Socials |
Key Contact at Bellus Health
Xianqi Kong
Director Of Chemistry
Bellus Health Email Formats
Bellus Health uses 1 email format. The most common is {first name} (e.g., john@bell.ca), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@bell.ca | 100% |
About Bellus Health
BELLUS Health is a clinical stage biotechnology company developing novel therapeutics for the treatment of chronic cough and other chronic disorders triggered by hypersensitization. The Company’s lead product candidate, BLU-5937, is a highly selective P2X3 antagonist being developed for the treatment of chronic cough and chronic pruritus. P2X3 receptors are channels expressed in sensory nerves throughout the body and play an important role in the sensitization of the nervous system to various stimuli. BELLUS is exploring how P2X3 activation contributes to irritation and pain, and whether inhibition of P2X3 receptors can help treat other afferent hypersensitization-related disorders. BELLUS Health is based in Laval, Quebec and its shares trade under the ticker BLU on both Nasdaq and the Toronto Stock Exchange.
Bellus Health revenue & valuation
| Annual revenue | $16,000 |
| Revenue per employee | $1,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $51,200 |
| Total funding | $200,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Bellus Health has 7 employees across 5 departments.
Departments
Number of employees
United States
Australia
Netherlands
United Kingdom
Frequently asked questions
4.8
40,000 users
